FIELD: medicine.
SUBSTANCE: invention represents a biologically active composition in the form of an orally dispersible tablet characterised by the fact that its contains dehydroepiandrosterone (DHEA) as an active ingredient and inert excipients: mannitol, sorbitol, manitol, crospovidone, copovidone, a lubricant, an intensive sweetener and a flavouring agent in certain proportions.
EFFECT: invention provides the new form of the biologically active additive of dehydroepiandrosterone.
3 cl, 2 ex
